Literature DB >> 32199510

Patients with mental health disorders in the COVID-19 epidemic.

Hao Yao1, Jian-Hua Chen2, Yi-Feng Xu3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32199510      PMCID: PMC7269717          DOI: 10.1016/S2215-0366(20)30090-0

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


× No keyword cloud information.
More than 60 000 infections have been confirmed worldwide in the coronavirus disease 2019 (COVID-19) epidemic, with most of these cases in China. Global attention has largely been focused on the infected patients and the frontline responders, with some marginalised populations in society having been overlooked. Here, we write to express our concerns with regards to the effect of the epidemic on people with mental health disorders. Ignorance of the differential impact of the epidemic on these patients will not only hinder any aims to prevent further spread of COVID-19, but will also augment already existing health inequalities. In China, 173 million people are living with mental health disorders, and neglect and stigma regarding these conditions still prevail in society. When epidemics arise, people with mental health disorders are generally more susceptible to infections for several reasons. First, mental health disorders can increase the risk of infections, including pneumonia. One report released on Feb 9, 2020, discussing a cluster of 50 cases of COVID-19 among inpatients in one psychiatric hospital in Wuhan, China, has raised concerns over the role of mental disorders in coronavirus transmission. Possible explanations include cognitive impairment, little awareness of risk, and diminished efforts regarding personal protection in patients, as well as confined conditions in psychiatric wards. Second, once infected with severe acute respiratory syndrome coronavirus 2—which results in COVID-19people with mental disorders can be exposed to more barriers in accessing timely health services, because of discrimination associated with mental ill-health in health-care settings. Additionally, mental health disorder comorbidities to COVID-19 will make the treatment more challenging and potentially less effective. Third, the COVID-19 epidemic has caused a parallel epidemic of fear, anxiety, and depression. People with mental health conditions could be more substantially influenced by the emotional responses brought on by the COVID-19 epidemic, resulting in relapses or worsening of an already existing mental health condition because of high susceptibility to stress compared with the general population. Finally, many people with mental health disorders attend regular outpatient visits for evaluations and prescriptions. However, nationwide regulations on travel and quarantine have resulted in these regular visits becoming more difficult and impractical to attend. Few voices of this large but vulnerable population of people with mental health disorders have been heard during this epidemic. Epidemics never affect all populations equally and inequalities can always drive the spread of infections. As mental health and public health professionals, we call for adequate and necessary attention to people with mental health disorders in the COVID-19 epidemic.
  4 in total

1.  Mental health in China: challenges and progress.

Authors:  Yu-Tao Xiang; Xin Yu; Norman Sartorius; Gabor S Ungvari; Helen F K Chiu
Journal:  Lancet       Date:  2012-11-17       Impact factor: 79.321

2.  Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies.

Authors:  Olena O Seminog; Michael J Goldacre
Journal:  Thorax       Date:  2012-12-15       Impact factor: 9.139

3.  Comorbidity of mental and physical diseases: a main challenge for medicine of the 21st century.

Authors:  Norman Sartorious
Journal:  Shanghai Arch Psychiatry       Date:  2013-04

4.  Evaluation of attitudes and knowledge toward mental disorders in a sample of the Chinese population using a web-based approach.

Authors:  Juan Li; Meng-Meng Zhang; Lin Zhao; Wen-Qiang Li; Jun-Lin Mu; Zhao-Hui Zhang
Journal:  BMC Psychiatry       Date:  2018-11-20       Impact factor: 3.630

  4 in total
  376 in total

1.  Time, love and tenderness: Doctors' online volunteering in Health Virtual Community searching for work-family balance.

Authors:  Shafiz Affendi Mohd Yusof; Norzaila Mohd Noor; Nafishah Othman
Journal:  J Infect Public Health       Date:  2020-12-17       Impact factor: 3.718

2.  Impacts of COVID-19 on Youth Mental Health, Substance Use, and Well-being: A Rapid Survey of Clinical and Community Samples: Répercussions de la COVID-19 sur la santé mentale, l'utilisation de substances et le bien-être des adolescents : un sondage rapide d'échantillons cliniques et communautaires.

Authors:  Lisa D Hawke; Skye Pamela Barbic; Aristotle Voineskos; Peter Szatmari; Kristin Cleverley; Em Hayes; Jacqueline Relihan; Mardi Daley; Darren Courtney; Amy Cheung; Karleigh Darnay; Joanna L Henderson
Journal:  Can J Psychiatry       Date:  2020-07-14       Impact factor: 4.356

3.  Mental Health of Communities during the COVID-19 Pandemic.

Authors:  Daniel Vigo; Scott Patten; Kathleen Pajer; Michael Krausz; Steven Taylor; Brian Rush; Giuseppe Raviola; Shekhar Saxena; Graham Thornicroft; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2020-05-11       Impact factor: 4.356

4.  Mental Distress in the United States at the Beginning of the COVID-19 Pandemic.

Authors:  Calliope Holingue; Luther G Kalb; Kira E Riehm; Daniel Bennett; Arie Kapteyn; Cindy B Veldhuis; Renee M Johnson; M Daniele Fallin; Frauke Kreuter; Elizabeth A Stuart; Johannes Thrul
Journal:  Am J Public Health       Date:  2020-09-17       Impact factor: 9.308

Review 5.  Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors:  Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal:  Front Pharmacol       Date:  2020-09-11       Impact factor: 5.810

Review 6.  Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.

Authors:  Ginenus Fekadu; Firomsa Bekele; Tadesse Tolossa; Getahun Fetensa; Ebisa Turi; Motuma Getachew; Eba Abdisa; Lemessa Assefa; Melkamu Afeta; Waktole Demisew; Dinka Dugassa; Dereje Chala Diriba; Busha Gamachu Labata
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-06-15

7.  Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic.

Authors:  Robert E Litman; Peter Sorantin; Elia E Acevedo-Diaz
Journal:  Innov Clin Neurosci       Date:  2021-01-01

8.  COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature.

Authors:  Niraj K Asthana; Eamonn Mehaffey; Daniel D Sewell
Journal:  Am J Geriatr Psychiatry       Date:  2021-06-12       Impact factor: 4.105

9.  Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic.

Authors:  Marom Bikson; Colleen A Hanlon; Adam J Woods; Bernadette T Gillick; Leigh Charvet; Claus Lamm; Graziella Madeo; Adrienn Holczer; Jorge Almeida; Andrea Antal; Mohammad Reza Ay; Chris Baeken; Daniel M Blumberger; Salvatore Campanella; Joan A Camprodon; Lasse Christiansen; Colleen Loo; Jennifer T Crinion; Paul Fitzgerald; Luigi Gallimberti; Peyman Ghobadi-Azbari; Iman Ghodratitoostani; Roland H Grabner; Gesa Hartwigsen; Akimasa Hirata; Adam Kirton; Helena Knotkova; Evgeny Krupitsky; Paola Marangolo; Ester M Nakamura-Palacios; Weronika Potok; Samir K Praharaj; Christian C Ruff; Gottfried Schlaug; Hartwig R Siebner; Charlotte J Stagg; Axel Thielscher; Nicole Wenderoth; Ti-Fei Yuan; Xiaochu Zhang; Hamed Ekhtiari
Journal:  Brain Stimul       Date:  2020-05-12       Impact factor: 8.955

Review 10.  Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.

Authors:  Guoliang Li; Ardan M Saguner; Jiaqi An; Yuye Ning; John D Day; Ligang Ding; Xavier Waintraub; Jie Wang
Journal:  Cardiol J       Date:  2020-08-13       Impact factor: 2.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.